Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced the appointment of Erica Jordan, Senior Vice President of Commercial to Chief Commercial Officer (CCO), Aesthetics.
- Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced the appointment of Erica Jordan, Senior Vice President of Commercial to Chief Commercial Officer (CCO), Aesthetics.
- As CCO, Erica will have global responsibility for all aesthetics commercial activity including commercial strategy, sales and marketing, branding, loyalty and engagement.
- “Given the importance of the DAXXIFY® launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me.
- Her extensive experience and strong ability to build partnerships both internally and externally, will be invaluable as we seek to maximize the market opportunity of our innovative products.”
“I’ve seen first-hand the tremendous excitement and potential that our product portfolio offers to the aesthetics market,” said Erica Jordan, Chief Commercial Officer, Aesthetics of Revance.